Last reviewed · How we verify
Interferon beta-1b, FRP within 15 days after randomization — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Interferon beta-1b, FRP within 15 days after randomization (Interferon beta-1b, FRP within 15 days after randomization) — Bayer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Interferon beta-1b, FRP within 15 days after randomization TARGET | Interferon beta-1b, FRP within 15 days after randomization | Bayer | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Interferon beta-1b, FRP within 15 days after randomization CI watch — RSS
- Interferon beta-1b, FRP within 15 days after randomization CI watch — Atom
- Interferon beta-1b, FRP within 15 days after randomization CI watch — JSON
- Interferon beta-1b, FRP within 15 days after randomization alone — RSS
Cite this brief
Drug Landscape (2026). Interferon beta-1b, FRP within 15 days after randomization — Competitive Intelligence Brief. https://druglandscape.com/ci/interferon-beta-1b-frp-within-15-days-after-randomization. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab